Arbutus Biopharma Corporation ABUS Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's invested capital?
- Arbutus Biopharma Corporation (ABUS) reported invested capital of $237.1M in Q1 2026.
- How has Arbutus Biopharma Corporation's invested capital changed year-over-year?
- Arbutus Biopharma Corporation's invested capital increased by 448.0% year-over-year, from $43.27M to $237.1M.
- What is the long-term trend for Arbutus Biopharma Corporation's invested capital?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's invested capital has grown at a 2.4% compound annual growth rate (CAGR), from $52.7M to $59.31M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).